Repligen promotes James Bylund to Chief Operating Officer effective Jan 1, 2022

REPLIGEN CORP

James Bylund promoted from SVP, Operations & IT to COO and principal operating officer, effective Jan 1, 2022.
Bylund joined Repligen in March 2020; prior 10 years at Thermo Fisher as VP & GM of Single Use Technologies.
He also held leadership roles at Fiserv (9 years) and Eli Lilly (7 years); holds B.S. from Utah State and MBA from Indiana.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

James Bylund

Chief Operating Officer

RGEN · REPLIGEN CORP

Effective: 2022-01-01
Filed: January 4, 2022, 6:59 PM ET

On January 3, 2022, Repligen Corporation (the “ Company ”) promoted James Bylund, the Company’s current Senior Vice President, Operations and Information Technologies, to the role of Chief Operating Officer of the Company, effective January 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James Bylund changed role as Chief Operating Officer at REPLIGEN CORP.

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On January 3, 2022, Repligen Corporation (the “ Company ”) promoted James Bylund, the Company’s current Senior Vice President, Operations and Information Technologies, to the role of Chief Operating Officer of the Company, effective January 1, 2022.

View on SEC.gov

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-22-001024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.